摘要 |
A compound of formula (I), or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof; Forumla (I) and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease. |
申请人 |
PFIZER LIMITED;PFIZER INC.;MATHIAS, JOHN, PAUL;MILLAN, DAVID, SIMON;LEWTHWAITE, RUSSELL, ANDREW;PHILLIPS, CHRISTOPHER |
发明人 |
MATHIAS, JOHN, PAUL;MILLAN, DAVID, SIMON;LEWTHWAITE, RUSSELL, ANDREW;PHILLIPS, CHRISTOPHER |